Replies to post #7403 on NDT Pharmaceuticals Inc (NDTP)

[Ecomike]

L-2 is acting like a bottom here at .0009

Close at .0010 and we have confirmed multi bottom at .0010

If the R/S was done with shares at .0001 the stock would only reach .10/share post split, and could kiss any biotech funding plans to Nasdaq good buy.

At .0010/share a 1000/1 RS only reaches a $1/share

At .005 on the day of R/S the stock would trade at $5/share post split, and could do what MHAN-pulled off about 8-9 years ago and raise $$$$ money and uplist directly to Nasdaq almost over night.

Not saying that will happen here, but....hard to sell the idea of Nasdaq uplist for a start up biotech unless they go right to $5/share and get stuff done fast.

I have no doubt there will major rally news long before a R/S.

I will hold and add.